The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Harbour BioMed brings advanced antibody discovery platforms to the table
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The U.S. oncology market is projected to soar from $81 billion in 2025 to $212 billion by 2034
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The antibody was designed and developed at Abzena’s Cambridge, UK,
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
Subscribe To Our Newsletter & Stay Updated
